| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |